References
- 1
Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL. et
al .
Comparative affinity of Duloxetine and Venlafaxine for serotonin and norepinephrine
transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Neuropsychopharmacology.
2001;
25
871-880
- 2
Reznik I, Rosen Y, Rosen B.
An acute ischaemic event associated with the use of venlafaxine: a case report and
proposed pathophysiological mechanisms.
J Psychopharmacol.
1999;
13
193-195
- 3
Supple EW, Graham RM, Powell Jr WJ.
Direct effects of alpha 2-adrenergic receptor stimulation on intravascular systemic
capacity in the dog.
Hypertension.
1988;
11
352-359
- 4
Stahl SM, Grady MM, Moret C, Briley M.
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with
other classes of antidepressants.
CNS Spectr.
2005;
10
732-747
- 5
Thase M.
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744
depressed patients.
J Clin Psychiatry.
1998;
59
502-508
- 6
Yoshida K, Higushi H, Takahashi H, Shimizu T.
Elevation of blood pressure induced by high-dose milnacipran.
Hum Psychopharmacol.
2005;
17
431
Correspondence
T. C. de Toledo Ferraz Alves
ABC Region Medical School
Fundação do ABC
Av. Príncipe de Gales
821·Caixa Postal 106 CEP: 09060-650
Santo André
São Paulo
Brazil
Phone: + 55/11/4993 54 40
Fax: +55/11/4993 54 40
Email: tania_alves@hotmail.com